SurgTech 2024 brings together the research strengths of the NIHR Surgical MedTech Co-operative, the Centre for HealthTech Innovation, and Leeds BRC Surgery Theme with methodological expertise in Surgical In Vitro Diagnostics and Devices, Leeds CTRU, and clinical translational capabilities through Leeds Teaching Hospitals Innovation PopUp.

This exciting two-day event will bring together clinical academics, allied health professionals, researchers from the engineering and physical sciences, methodologists, public and patients, industry, and experts in market access, medical device regulation and commercialisation in a truly multi-disciplinary forum to build networks, explore opportunities for new collaborations, and celebrate recent successes.

Click here for further details

Charing Cross (CX) stands at the forefront of vascular and endovascular education, as the leading symposium in the field. The CX 2024 program marks the beginning of a new three-year cycle, dedicated to raising vascular and endovascular controversies so that our esteemed faculty, comprised of world-class experts, can engage in rigorous discussions and challenge the existing evidence in pursuit of reaching a consensus.

Controversies will serve as the central theme for CX 2024. We will be welcoming leading professionals, educators and enthusiasts from the world of vascular medicine. Together, we will delve in to the controversies in the fields of vascular and endovascular medicine which affect patient care and the daily practice of healthcare providers in this area.

In 2024, the Charing Cross Symposium will relocate to a new venue – ExCeL London, UK. This move opens up exciting possibilities for hands-on education, including a more robust workshop offering with open access to all in-person delegates. As always, CX 2024 will prioritize education, innovation and evidence, featuring the hottest topics in the space, presented by world-renowned expert speakers.

The Multi-Level CTO Endovascular Course brings together a multidisciplinary group of vascular specialists from Europe and Middle East to engage in the highest standard educational format with a spirit of collegiality and inclusion.

The course will focus on the latest advances and techniques in endovascular revascularization of chronic total occlusions. Our program, thought and realized in collaboration with our European Expert Committee, is made up of recorded case-based discussions, numerous live case transmissions, plenty of “tips & tricks” sharing and practical talks about CTO recanalization, all guided by the highest caliber global experts-in-the-field.

Our mission is to be the first educational course in the field of CTO to cover all endovascular levels, from head to toe.

The multi-level aspect will reflect clear step-by-step approaches to all kind of revascularizations, more experienced cutting-edge education to overcome daily difficulties and extreme cases and techniques will be integrated into the program.

Frontline strategies, in-depth material knowledge, dedicated but unfamiliar tools and unexpected problem solving are just some of the ingredients of this course in the peripheral world.

This course will offer a great opportunity for young operators to improve their technique and attend a practical training.

STARS offers a unique opportunity to engage with a selected national and international faculty discussing and debating critical issues in vascular and endovascular surgery.

STARS will continue to be an informal and interactive forum to exchange expertise and knowledge between attendees and key opinion leaders. Taking place in the newly renovated County Hall in central London, STARS also offers an excellent opportunity for networking and exposure to the newest technologies and recent developments in the field of complex vascular interventions.

Click here for more details

This newly designed course has been developed to meet the needs of interdisciplinary healthcare practitioners working in partnership with people in relation to peripheral vascular disease (PVD), which encompasses both arterial, venous and lymphatic diseases

Click here for further information